Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.13% | $20.59M | $509.58B | 76.06% | 81 Outperform | |
| Roche Holding AG | 1.17% | $11.29M | CHF276.02B | 52.12% | 73 Outperform | |
| Novartis | 1.12% | $10.89M | $271.38B | 48.00% | 80 Outperform | |
| Royal Bank Of Canada | 0.99% | $9.55M | $236.74B | 40.48% | 75 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.86% | $8.30M | €311.03B | -8.68% | 78 Outperform | |
| AstraZeneca | 0.86% | $8.30M | $291.02B | 41.13% | 79 Outperform | |
| ― | 0.74% | $7.21M | ― | ― | ― | |
| Toyota Motor | 0.71% | $6.88M | ¥48.41T | 27.74% | 80 Outperform | |
| Rolls-Royce Holdings | 0.69% | $6.68M | £106.91B | 138.52% | 71 Outperform | |
| Sony | 0.60% | $5.78M | ¥23.85T | 18.25% | 73 Outperform |